

Postponed! BioBoot Camp: Business Essentials for Life Sciences Startups
We regret to inform you that our BioBoot Camp event at the Dorsey and Whitney Offices on Tuesday, May 24, 2022 has been postponed. We made the decision to postpone in order to provide the most value to the startups in our life sciences ecosystem at a later date this fall.
Thank you for your understanding! Please plan to join us for a dynamic, informative day designed specifically for our life sciences startup community later in the year. Contact Natalie Allen at nallen@cobioscience.com.
BioBoot Camp addresses the business essentials and resources for life sciences startups. Registration is complimentary and available to qualified startups in the life sciences industries.
AGENDA
9:00 – 9:30 a.m.
Starting a Life Sciences Company
Ethan Mann, Ph.D., M.B.A., CEO, Validus Therapeutics
9:30 – 10:30 a.m.
Company Formation
Michael Weiner, Partner, Dorsey & Whitney
10:30 – 11:30 a.m.
Building Your Management Team
Tom Cycyota, President & CEO, AlloSource
11:30 – 12:30 p.m.
IP – Protecting your Technology
Angie Morrison, Partner, Dorsey & Whitney
12:30 – 1:15 p.m.
Lunch
1:15 – 1:45 p.m.
Licensing Strategies
Kerith Kanaber, Partner, Dorsey & Whitney
2:00 – 3:00 p.m.
Company Valuation
Peter Adams, Managing Partner, Rockies Venture Club
Break
3:00 – 3:30 p.m.
State, Grant & Community Resources
Elyse Blazevich, President & CEO, CBSA
April Giles, Vice President of Business Development, Fitzsimons Innovation Community
Kevin Noble, Life Sciences Client Manager, Innosphere Ventures
3:30 – 4:15 p.m.
Early Financing Overview
Michael Weiner, Partner, Dorsey & Whitney
4:15 – 5:00 p.m.
Early-Stage Fundraising – An Investor Perspective
Peter Adams, Managing Partner, Rockies Venture Club
5:00 – 6:00 p.m.
Networking
REGISTRATION REQUIREMENTS
Registration is complimentary for qualified companies and attendees.
Attendees must fit the following criteria:
- Startup or early-stage life sciences companies working in R&D towards the commercialization of one or more specific technologies or therapeutic areas of development (medical device, diagnostic, biotech, pharma, digital health)
- Entrepreneurs or researchers considering the formation of an entity in the life science sector


